|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gatenby RA and Gillies RJ: A
microenvironmental model of carcinogenesis. Nat Rev Cancer.
8:56–61. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Albini A and Sporn MB: The tumour
microenvironment as a target for chemoprevention. Nat Rev Cancer.
7:139–147. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosich L, Saborit-Villarroya I,
López-Guerra M, Xargay-Torrent S, Montraveta A, Aymerich M,
Villamor N, Campo E, Pérez-Galán P, Roué G, et al: The
phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes
resistance signals derived from microenvironment by regulating the
Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells.
Haematologica. 98:1739–1747. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oellerich MF and Potente M: FOXOs and
sirtuins in vascular growth, maintenance, and aging. Circ Res.
110:1238–1251. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Becker T, Loch G, Beyer M, Zinke I,
Aschenbrenner AC, Carrera P, Inhester T, Schultze JL and Hoch M:
FOXO-dependent regulation of innate immune homeostasis. Nature.
463:369–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Monsalve M and Olmos Y: The complex
biology of FOXO. Curr Drug Targets. 12:1322–1350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hedrick SM, Michelini Hess R, Doedens AL,
Goldrath AW and Stone EL: FOXO transcription factors throughout T
cell biology. Nat Rev Immunol. 12:649–661. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seiler F, Hellberg J, Lepper PM,
Kamyschnikow A, Herr C, Bischoff M, Langer F, Schäfers HJ, Lammert
F, Menger MD, et al: FOXO transcription factors regulate innate
immune mechanisms in respiratory epithelial cells. J Immunol.
190:1603–1613. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He L, Yang X, Cao X, Liu F, Quan M and Cao
J: Casticin induces growth suppression and cell cycle arrest
through activation of FOXO3a in hepatocellular carcinoma. Oncol
Rep. 29:103–108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yung MM, Chan DW, Liu VW, Yao KM and Ngan
HY: Activation of AMPK inhibits cervical cancer cell growth through
AKT/FOXO3a/FOXM1 signaling cascade. BMC Cancer. 13:3272013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bullock MD, Bruce A, Sreekumar R, Curtis
N, Cheung T, Reading I, Primrose JN, Ottensmeier C, Packham GK,
Thomas G and Mirnezami AH: FOXO3 expression during colorectal
cancer progression: Biomarker potential reflects a tumour
suppressor role. Br J Cancer. 109:387–394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tenbaum SP, Ordóñez-Morán P, Puig I,
Chicote I, Arqués O, Landolfi S, Fernández Y, Herance JR, Gispert
JD, Mendizabal L, et al: β-catenin confers resistance to PI3K and
AKT inhibitors and subverts FOXO3a to promote metastasis in colon
cancer. Nat Med. 18:892–901. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Y, Zhang W, Guo Z, Ma F, Wu Y, Bai Y,
Gong W, Chen Y, Cheng T, Zhi F, et al: Inhibition of the
transcription factor Sp1 suppresses colon cancer stem cell growth
and induces apoptosis in vitro and in nude mouse xenografts.
Oncol Rep. 30:1782–1792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim DW, Ko SM, Jeon YJ, Noh YW, Choi NJ,
Cho SD, Moon HS, Cho YS, Shin JC, Park SM, et al:
Anti-proliferative effect of honokiol in oral squamous cancer
through the regulation of specificity protein 1. Int J Oncol.
43:1103–1110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jeon YJ, Ko SM, Cho JH, Chae JI and Shim
JH: The HDAC inhibitor, panobinostat, induces apoptosis by
suppressing the expresssion of specificity protein 1 in oral
squamous cell carcinoma. Int J Mol Med. 32:860–866. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karin M, Liu Z and Zandi E: AP-1 function
and regulation. Curr Opin Cell Biol. 9:240–246. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Greer EL and Brunet A: FOXO transcription
factors at the interface between longevity and tumor suppression.
Oncogene. 24:7410–7425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Z, Zhang H, Chen Y, Fan L and Fang J:
Forkhead transcription factor FOXO3a protein activates nuclear
factor κB through B-cell lymphoma/leukemia 10 (BCL10) protein and
promotes tumor cell survival in serum deprivation. J Biol Chem.
287:17737–17745. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Philipsen S and Suske G: A tale of three
fingers: The family of mammalian Sp/XKLF transcription factors.
Nucleic Acids Res. 27:2991–3000. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li L, He S, Sun JM and Davie JR: Gene
regulation by Sp1 and Sp3. Biochem Cell Biol. 82:460–471. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schreiber M, Baumann B, Cotton M, Angel P
and Wagner EF: Fos is an essential component of the mammalian UV
response. EMBO J. 14:5338–5349. 1995.PubMed/NCBI
|
|
24
|
Lania L, Majello B and De Luca P:
Transcriptional regulation by the Sp family proteins. Int J Biochem
Cell Biol. 29:1313–1323. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suske G: The Sp-family of transcription
factors. Gene. 238:291–300. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marin M, Karis A, Visser P, Grosveld F and
Philipsen S: Transcription factor Sp1 is essential for early
embryonic development but dispensable for cell growth and
differentiation. Cell. 89:619–628. 1997. View Article : Google Scholar : PubMed/NCBI
|
